- PMID 16497842. Gore, CJ; Clark, SA; Saunders, PU (September 2007). "
Nonhematological mechanisms of
improved sea-level
performance after hypoxic exposure"...
- Division. Gore, C.J.; Clark, S.A.; Saunders, P.U. (September 2007). "
Nonhematological mechanisms of
improved sea-level
performance after hypoxic exposure"...
- |journal=
ignored (help) Gore CJ,
Clark SA,
Saunders PU (September 2007). "
Nonhematological mechanisms of
improved sea-level
performance after hypoxic exposure"...
-
conditioning VO2 max Gore, C.J., Clark, S.A., Saunders, P.U. (2007).
Nonhematological mechanisms of
improved sea-level
performance after hypoxic exposure...
- S2CID 2536000. Gore, CJ; Clark, SA; Saunders, PU (September 2007). "
Nonhematological mechanisms of
improved sea-level
performance after hypoxic exposure"...
-
without which the
cancer cells cannot make protein. The most
common nonhematological adverse reactions of
asparaginase erwinia chrysanthemi (recombinant)...
-
include anemia, thrombocytopenia, and neutropenia. The most
common nonhematologic adverse reactions include infections and edema.
Immunologic side effects...
-
cancer (NSCLC) –
nonconsecutive case
series –
noncontiguous lymphoma –
nonhematologic cancer – noni –
nonlytic –
nonmalignant –
nonmalignant hematologic disorder...
- diseases.
While occasionally used
experimentally in
nonmalignant and
nonhematologic indications such as
severe disabling auto-immune
disease and cardiovascular...
